These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32538716)

  • 21. A Decade's Progress in the Development of Molecular Imaging Agents Targeting the Growth Hormone Secretagogue Receptor.
    Childs MD; Luyt LG
    Mol Imaging; 2020; 19():1536012120952623. PubMed ID: 33104445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions.
    Gupta D; Patterson AM; Osborne-Lawrence S; Bookout AL; Varshney S; Shankar K; Singh O; Metzger NP; Richard CP; Wyler SC; Elmquist JK; Zigman JM
    Mol Metab; 2021 Nov; 53():101258. PubMed ID: 34023483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Belly to Brain: Targeting the Ghrelin Receptor in Appetite and Food Intake Regulation.
    Howick K; Griffin BT; Cryan JF; Schellekens H
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of Growth Hormone Secretagogue Receptor in Kisspeptin Neurons in Female Mice Blocks Diet-Induced Obesity.
    Conde K; Kulyk D; Vanschaik A; Daisey S; Rojas C; Wiersielis K; Yasrebi A; Degroat TJ; Sun Y; Roepke TA
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin and growth hormone secretagogue receptor (GHSR) genes are not commonly involved in growth or weight abnormalities in an Israeli pediatric population.
    Hess O; Admoni O; Khayat M; Elias G; Almagor T; Shalev SA; Tenenbaum-Rakover Y
    J Pediatr Endocrinol Metab; 2012; 25(5-6):537-40. PubMed ID: 22876551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Loss of Ghrelin Receptor and Cannabinoid CB1 Receptor in Mice Decreases Survival but does not Additively Reduce Body Weight or Eating.
    Mani BK; Castorena CM; Vianna CR; Lee CE; Metzger NP; Vijayaraghavan P; Osborne-Lawrence S; Elmquist JK; Zigman JM
    Neuroscience; 2020 Nov; 447():53-62. PubMed ID: 31520709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue.
    Shankar K; Metzger NP; Singh O; Mani BK; Osborne-Lawrence S; Varshney S; Gupta D; Ogden SB; Takemi S; Richard CP; Nandy K; Liu C; Zigman JM
    Mol Metab; 2021 Nov; 53():101327. PubMed ID: 34428557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice lacking ghrelin receptors resist the development of diet-induced obesity.
    Zigman JM; Nakano Y; Coppari R; Balthasar N; Marcus JN; Lee CE; Jones JE; Deysher AE; Waxman AR; White RD; Williams TD; Lachey JL; Seeley RJ; Lowell BB; Elmquist JK
    J Clin Invest; 2005 Dec; 115(12):3564-72. PubMed ID: 16322794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food intake and interdigestive gastrointestinal motility in ghrelin receptor mutant rats.
    Bülbül M; Babygirija R; Zheng J; Ludwig K; Xu H; Lazar J; Takahashi T
    J Gastroenterol; 2011 Apr; 46(4):469-78. PubMed ID: 21258824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GHSR signalling in perinatal phases is involved in liver metabolism at puberty.
    Ferreira-Junior MD; Cavalcante KVN; Xavier CH; Vanzela EC; Boschero AC; Matafome P; Gomes RM
    J Endocrinol; 2024 Oct; 263(1):. PubMed ID: 39045853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in Small Molecule and Biologic Therapeutics Targeting Ghrelin Signaling.
    McGovern KR; Darling JE; Hougland JL
    Mini Rev Med Chem; 2016; 16(6):465-80. PubMed ID: 26202202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver-expressed antimicrobial peptide 2 functions independently of growth hormone secretagogue receptor in calorie-restricted mice.
    Islam MN; Zhang W; Sakai K; Nakazato Y; Tanida R; Sakoda H; Takei T; Takao T; Nakazato M
    Peptides; 2022 May; 151():170763. PubMed ID: 35151767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ghrelin and the growth hormone secretagogue receptor in growth and development.
    Chanoine JP; De Waele K; Walia P
    Int J Obes (Lond); 2009 Apr; 33 Suppl 1():S48-52. PubMed ID: 19363508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecule ghrelin receptor inverse agonists and antagonists.
    Cameron KO; Bhattacharya SK; Loomis AK
    J Med Chem; 2014 Nov; 57(21):8671-91. PubMed ID: 25036503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrinsic ghrelin in the paraventricular nucleus increases small intestinal motility in rats by activating central growth hormone secretagogue and enteric cholinergic receptors.
    Wang Y; Chen F; Shi H; Jiang J; Li H; Qin B; Li Y
    Peptides; 2015 Dec; 74():43-9. PubMed ID: 26431788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ghrelin gene products and the regulation of food intake and gut motility.
    Chen CY; Asakawa A; Fujimiya M; Lee SD; Inui A
    Pharmacol Rev; 2009 Dec; 61(4):430-81. PubMed ID: 20038570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutralizing circulating ghrelin by expressing a growth hormone secretagogue receptor-based protein protects against high-fat diet-induced obesity in mice.
    Gagnon J; Zhu L; Anini Y; Wang Q
    Gene Ther; 2015 Sep; 22(9):750-7. PubMed ID: 25965396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
    Mager U; Degenhardt T; Pulkkinen L; Kolehmainen M; Tolppanen AM; Lindström J; Eriksson JG; Carlberg C; Tuomilehto J; Uusitupa M;
    PLoS One; 2008 Aug; 3(8):e2941. PubMed ID: 18698404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor agonist capromorelin in veterinary medicine.
    Rathore M; Das N; Ghosh N; Guha R
    Vet Res Commun; 2024 Feb; 48(1):1-10. PubMed ID: 37493940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational Design, Synthesis, and Pharmacological Characterization of Novel Ghrelin Receptor Inverse Agonists as Potential Treatment against Obesity-Related Metabolic Diseases.
    Daina A; Giuliano C; Pietra C; Wang J; Chi Y; Zou Z; Li F; Yan Z; Zhou Y; Guainazzi A; Garcia Rubio S; Zoete V
    J Med Chem; 2018 Dec; 61(24):11039-11060. PubMed ID: 30265805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.